Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Gregg C Sylvester"'
Autor:
Huong Q. McLean, Joshua G. Petrie, Kayla E. Hanson, Jennifer K. Meece, Melissa A. Rolfes, Gregg C. Sylvester, Gabriele Neumann, Yoshihiro Kawaoka, Edward A. Belongia
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:201-205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::367891d8acfe89bbf46bd8492ecd6e36
https://doi.org/10.15585/mmwr.mm7208a1
https://doi.org/10.15585/mmwr.mm7208a1
Autor:
Constantina Boikos, Mahrukh Imran, Van Hung Nguyen, Thierry Ducruet, Gregg C. Sylvester, James A. Mansi
Publikováno v:
Vaccines, Vol 9, Iss 8, p 862 (2021)
MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose trivalent inactivated influenza vaccine (HD-IIV3) elicit an enhanced immune response in older adults compared to standard, quadrivalent inactivated influenza vaccines (II
Externí odkaz:
https://doaj.org/article/799e06af1af2428b8fd40ca68202092d
Autor:
Constantina Boikos, Lauren Fischer, James A. Mansi, Gregg C Sylvester, Daniel P O'Brien, Joseph Vasey
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The effectiveness of standard, egg-derived quadrivalent influenza vaccines (IIV4) may be reduced in adults ≥65 years of age, largely because of immunosenescence. An MF59-adjuvanted trivalent influenza vaccine (aIIV3) and a high-dose triv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84672cbf6e386b80615e85255ce33f4f
http://europepmc.org/articles/PMC8423477
http://europepmc.org/articles/PMC8423477
Autor:
James A. Mansi, Constantina Boikos, Lauren Fischer, Joseph Vasey, Gregg C Sylvester, Daniel P O'Brien
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The cell-propagated inactivated quadrivalent influenza vaccine (ccIIV4) may offer improved protection in seasons where egg-derived influenza viruses undergo mutations that affect antigenicity. This study estimated the relative vaccine effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2196d66cf8fd5eb2d731b581330378
http://europepmc.org/articles/PMC8326580
http://europepmc.org/articles/PMC8326580
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Influenza antigens may undergo adaptive mutations during egg-based vaccine production. In the 2017–2018 influenza season, quadrivalent, inactivated cell-derived influenza vaccine (ccIIV4) vaccine was produced using A(H3N2) seed virus pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::310e604fe5851068fdfaa9e67d8fc64a
https://doi.org/10.1093/cid/ciaa371
https://doi.org/10.1093/cid/ciaa371
Autor:
Gregg C Sylvester, Thierry Ducruet, Mahrukh Imran, Van Hung Nguyen, James A. Mansi, Constantina Boikos
Publikováno v:
Vaccines, Vol 9, Iss 862, p 862 (2021)
Vaccines
Volume 9
Issue 8
Vaccines
Volume 9
Issue 8
MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose trivalent inactivated influenza vaccine (HD-IIV3) elicit an enhanced immune response in older adults compared to standard, quadrivalent inactivated influenza vaccines (II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76601dab82f854e7f128106e75d8df44
https://www.mdpi.com/2076-393X/9/8/862
https://www.mdpi.com/2076-393X/9/8/862
Autor:
James A. Mansi, Van Hung Nguyen, Thierry Ducruet, Constantina Boikos, Gregg C Sylvester, Mahrukh Imran
Publikováno v:
Open Forum Infectious Diseases
Background Higher rates of influenza-related morbidity and mortality occur in individuals with underlying medical conditions. To improve vaccine effectiveness, cell-based technology for influenza vaccine manufacturing has been developed. Cell-derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f7b716e942ab5995aebb94ba535df8
http://europepmc.org/articles/PMC8314952
http://europepmc.org/articles/PMC8314952
Publikováno v:
Open Forum Infectious Diseases
Background Individuals with health conditions have shown higher rates of influenza-related morbidity and mortality compared to healthy individuals and are often prioritized for influenza vaccination. However, vaccination with egg-derived standard qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820b55cc2ad420d35a623ee608e562ed
http://europepmc.org/articles/PMC7776880
http://europepmc.org/articles/PMC7776880
Autor:
McLean, Huong Q.1 mclean.huong@marshfieldresearch.org, Petrie, Joshua G.1, Hanson, Kayla E.1, Meece, Jennifer K.1, Rolfes, Melissa A.2, Sylvester, Gregg C.3, Neumann, Gabriele4, Yoshihiro Kawaoka4, Belongia, Edward A.1
Publikováno v:
MMWR: Morbidity & Mortality Weekly Report. 2/24/2023, Vol. 72 Issue 8, p201-205. 5p. 2 Charts.
Publikováno v:
Human Vaccines & Immunotherapeutics
Previous research has suggested that reducing the US 4-dose PCV13 schedule to a 3-dose schedule may provide cost savings, despite more childhood pneumococcal disease. The study also stressed that dose reduction should be coupled with improved PCV adh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce070d0d0961f3bd6b6fe807da409ce8
https://pubmed.ncbi.nlm.nih.gov/26376039
https://pubmed.ncbi.nlm.nih.gov/26376039